**Core Concept**
Tumor markers are substances produced by cancer cells or in response to cancer that can be used for early detection, diagnosis, or monitoring of cancer progression. These markers can be proteins, hormones, or other substances that are elevated in the blood or other bodily fluids in the presence of cancer.

**Why the Correct Answer is Right**
The correct answer is not explicitly provided, so I will provide a general explanation. Tumor markers are used in the management of various cancers, including colorectal, breast, lung, and prostate cancer. Common tumor markers include CEA (carcinoembryonic antigen), CA-125 (cancer antigen 125), PSA (prostate-specific antigen), and AFP (alpha-fetoprotein). These markers are often used in conjunction with imaging studies and other diagnostic tools to aid in cancer diagnosis and monitoring.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, but if it were a tumor marker, it would be a valid answer. However, without the option, we cannot evaluate its correctness.
**Option B:** This option is also not provided, and therefore, we cannot determine if it is a tumor marker or not.
**Option C:** This option is not provided, and without it, we cannot assess its validity as a tumor marker.
**Option D:** This option is also not provided, and therefore, we cannot determine if it is a tumor marker or not.

**Clinical Pearl / High-Yield Fact**
Some tumor markers, such as PSA for prostate cancer, can be elevated in non-cancerous conditions, such as benign prostatic hyperplasia. Therefore, it is essential to interpret tumor marker results in the context of the patient's clinical presentation and other diagnostic findings.

**Correct Answer: Not Provided**